82 FR 17847 - Office of the Director, Office of Science Policy; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 70 (April 13, 2017)

Page Range		17847-17848
FR Document		2017-07511

Federal Register, Volume 82 Issue 70 (Thursday, April 13, 2017)

[Federal Register Volume 82, Number 70 (Thursday, April 13, 2017)]
[Notices]
[Pages 17847-17848]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-07511]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy; Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 11, 2017.
    Time: 2:00 p.m.-4:30 p.m. Eastern.
    Agenda: Presentations and discussions regarding: (1) The Blue 
Ribbon Panel draft report on the 2014 variola virus incident on the 
NIH Bethesda campus; (2) stakeholder engagement on implementation of 
the U.S. Government Policy for Institutional Oversight of Life 
Sciences Dual Use Research of Concern (DURC); and (3) other business 
of the Board.

[[Page 17848]]

    Place: Telephone conference call only (no in-person meeting), 
Public Dial-in (US Toll Free): 1-866-939-3921, Confirmation Number: 
44675525.
    Contact Person: Jessica Tucker, Ph.D., Executive Director, 
NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland 20892, (301) 451-4431, 
[email protected].

    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity (NSABB) 
to provide advice regarding federal oversight of dual use research--
defined as legitimate biological research that generates information 
and technologies that could be misused to pose a biological threat to 
public health and/or national security.
    The toll-free teleconference line will be open to the public at 
1:30 p.m. to allow time for operator-assisted check-in. Members of the 
public planning to participate in the teleconference may also pre-
register online via the link provided below or by calling Palladian 
Partners, Inc. (Contact: Carly Sullivan at 301-318-0841). Pre-
registration will close at 12:00 p.m. Eastern on May 8, 2017. After 
that time, attendees may register their information with the 
teleconference operator upon dialing into the meeting. Individuals who 
plan to participate and need special assistance should submit a request 
to the contact person listed on this notice by May 3, 2017.
    Meeting materials: The meeting agenda, background material, and 
online pre-registration will be available at: https://palladianpartners.cvent.com/nsabbmay2017. Please check this Web site 
for updates.
    Public Comments: Time will be allotted on the agenda for the 
delivery of oral public comments. Members of the public interested in 
delivering prepared comments relevant to the mission of the NSABB 
should indicate so upon registration. Sign-up for delivering prepared 
oral comments will be limited to one per person or organization 
representative per open comment period. Individual comments will be 
time-limited to facilitate broad participation from multiple speakers.
    In addition, interested persons may file written comments at any 
time with the Board via an email sent to [email protected] or by regular 
mail sent to the Contact Person listed on this notice. Written 
statements should include the name, contact information, and when 
applicable, the professional affiliation of the interested person. 
Written comments received by 12:00 p.m. Eastern on May 8, 2017 will be 
relayed to the NSABB prior to the teleconference meeting. Any written 
comments received after this deadline will be provided to the Board 
either before or after the meeting, depending on the volume of comments 
received and the time required to process them in accordance with 
privacy regulations and other applicable federal policies.

    Dated: April 10, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07511 Filed 4-12-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 70 / Thursday, April 13, 2017 / Notices 17847

Dated: April 10, 2017. Room 7353, 6707 Democracy Boulevard, Days; CCRHB-Clinical Center Governing
Natasha M. Copeland, Bethesda, MD 20892–2542, (301) 594–8898, Board Joint Session; Delayed Reporting Root
barnardm@extra.niddk.nih.gov. Cause Analysis; Clinical Trials Support
Program Analyst, Office of Federal Advisory
This notice is being published less than 15 Realignment.
Committee Policy.
days prior to the meeting due to the timing Place: Conference Room 6C6 (except for
[FR Doc. 2017–07508 Filed 4–12–17; 8:45 am] Clinical Center Tour), Building 31, National
limitations imposed by the review and
BILLING CODE 4140–01–P funding cycle. Institutes of Health, Bethesda, MD 20892.
Closed: 3:20 p.m. to 5:00 p.m.
(Catalogue of Federal Domestic Assistance Agenda: Identification of Candidates for
Program Nos. 93.847, Diabetes, Leadership Roles.
DEPARTMENT OF HEALTH AND Endocrinology and Metabolic Research;
HUMAN SERVICES Place: Conference Room 6C6, Building 31,
93.848, Digestive Diseases and Nutrition National Institutes of Health, Bethesda, MD
Research; 93.849, Kidney Diseases, Urology 20892.
National Institutes of Health and Hematology Research, National Institutes Contact Person: Gretchen Wood, Staff
of Health, HHS) Assistant, National Institutes of Health,
National Institute of Diabetes and
Dated: April 10, 2017. Office of the Director, One Center Drive,
Digestive and Kidney Diseases; Notice Building 1, Room 126, Bethesda, MD 20892,
of Closed Meetings David Clary,
301–496–4272, woodgs@od.nih.gov.
Program Analyst, Office of Federal Advisory
Pursuant to section 10(d) of the Committee Policy. Any interested person may file
Federal Advisory Committee Act, as [FR Doc. 2017–07510 Filed 4–12–17; 8:45 am] written comments with the committee
amended (5 U.S.C. App.), notice is BILLING CODE 4140–01–P
by forwarding the statement to the
hereby given of the following meetings. Contact Person listed on this notice. The
The meetings will be closed to the statement should include the name,
public in accordance with the DEPARTMENT OF HEALTH AND address, telephone number and when
provisions set forth in sections HUMAN SERVICES applicable, the business or professional
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., affiliation of the interested person.
as amended. The grant applications and National Institutes of Health In the interest of security, NIH has
the discussions could disclose instituted stringent procedures for
confidential trade secrets or commercial Office of the Director; Notice of entrance onto the NIH campus. All
property such as patentable material, Meeting visitor vehicles, including taxicabs,
and personal information concerning hotel, and airport shuttles will be
Pursuant to section 10(d) of the inspected before being allowed on
individuals associated with the grant Federal Advisory Committee Act, as
applications, the disclosure of which campus. Visitors will be asked to show
amended (5 U.S.C. App), notice is one form of identification (for example,
would constitute a clearly unwarranted hereby given of a meeting of the NIH
invasion of personal privacy. a government-issued photo ID, driver’s
Clinical Center Research Hospital license, or passport) and to state the
Name of Committee: National Institute of Board. purpose of their visit.
Diabetes and Digestive and Kidney Diseases The meeting will be open to the
Special Emphasis Panel; Loan Repayment public as indicated below, with Dated: April 7, 2017.
Application Review. attendance limited to space available. Anna Snouffer,
Date: April 27, 2017. Deputy Director, Office of Federal Advisory
Individuals who plan to attend and
Time: 2:00 p.m. to 5:00 p.m. Committee Policy.
Agenda: To review and evaluate grant need special assistance, such as sign
applications. language interpretation or other [FR Doc. 2017–07427 Filed 4–12–17; 8:45 am]
Place: National Institutes of Health, Two reasonable accommodations, should BILLING CODE 4140–01–P
Democracy Plaza, 6707 Democracy notify the Contact Person listed below
Boulevard, Bethesda, MD 20892 (Telephone in advance of the meeting.
Conference Call). The portion of the meeting devoted to DEPARTMENT OF HEALTH AND
Contact Person: John F. Connaughton, the identification and evaluation of HUMAN SERVICES
Ph.D., Chief, Scientific Review Branch, specific candidates for consideration for
Review Branch, DEA, NIDDK, National leadership positions in the Clinical National Institutes of Health
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
Center will be closed to the public in Office of the Director, Office of Science
5452, (301) 594–7797, connaughtonj@ accordance with the provisions set forth Policy; Meeting
extra.niddk.nih.gov. in section 552b(c)(9)(B) and 552b(c)(6),
This notice is being published less than 15 Title 5 U.S.C., as amended. Premature Pursuant to section 10(a) of the
days prior to the meeting due to the timing disclosure of potential candidates and Federal Advisory Committee Act, as
limitations imposed by the review and their qualifications, as well as the amended (5 U.S.C. App.), notice is
funding cycle. discussions by the committee, could hereby given of the meeting of the
Name of Committee: National Institute of significantly frustrate NIH’s ability to National Science Advisory Board for
Diabetes and Digestive and Kidney Diseases recruit these individuals and the Biosecurity (NSABB).
Special Emphasis Panel; Time-Sensitive consideration of personnel Name of Committee: National Science
Obesity Policy and Program Evaluation. qualifications, performance, and the Advisory Board for Biosecurity.
Date: April 28, 2017. competence of individuals as candidates Date: May 11, 2017.
Time: 2:00 p.m. to 3:30 p.m.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

would constitute a clearly unwarranted Time: 2:00 p.m.–4:30 p.m. Eastern.
Agenda: To review and evaluate grant Agenda: Presentations and discussions
applications.
invasion of personal privacy.
regarding: (1) The Blue Ribbon Panel draft
Place: National Institutes of Health, Two Name of Committee: NIH Clinical Center report on the 2014 variola virus incident on
Democracy Plaza, 6707 Democracy Research Hospital Board. the NIH Bethesda campus; (2) stakeholder
Boulevard, Bethesda, MD 20892 (Telephone Date: April 28, 2017. engagement on implementation of the U.S.
Conference Call). Open: 8:30 a.m. to 3:20 p.m. Government Policy for Institutional
Contact Person: Michele L. Barnard, Ph.D., Agenda: Clinical Center Tour (8:30–9:45) Oversight of Life Sciences Dual Use Research
Scientific Review Officer, Review Branch, Welcome and Board Chair’s Overview; NIH of Concern (DURC); and (3) other business of
DEA, NIDDK, National Institutes of Health, Director’s Remarks, NIH CC CEO: First 100 the Board.

VerDate Sep<11>2014 17:51 Apr 12, 2017 Jkt 241001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1

Document Created: 2017-04-13 01:09:22
Document Modified: 2017-04-13 01:09:22

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 11, 2017.
FR Citation		82 FR 17847

82 FR 17847 - Office of the Director, Office of Science Policy; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 70 (April 13, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health